JAGSNPHARM
JAGSONPAL PHARMACEUTICALS

243.05 -5.07 (-2.09%)

Don't consider investing in JAGSNPHARM now, it is risky at the moment

17 Sep, 20255 min read

JAGSNPHARM significantly underperformed today. On a longer term basis, investors in JAGSONPAL PHARMACEUTICALS made +0.1% per day. Wednesday's performance of -2.09% was a significant underperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}